title: Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
abstract: The expanding arsenal of transgenic mice has created a powerful tool for investigating the biological mechanisms involved in ototoxicity. However, cisplatin ototoxicity is difficult to investigate in mice because of their small size and vulnerability to death by nephrotoxicity. To overcome this problem, we developed a strategy for promoting cisplatin-induced ototoxicity by coadministration of furosemide a loop diuretic. A dose-response study identified 200 mg/kg of furosemide as the optimal dose for disrupting the stria vascularis and opening the blood-ear barrier. Our analysis of stria pathology indicated that the optimal period for administering cisplatin was 1 h after furosemide treatment. Combined treatment with 0.5 mg/kg of cisplatin and 200 mg/kg furosemide resulted in only moderate loss of outer hair cells in the basal 20% of the cochlea, only mild threshold shifts and minimal loss of distortion product otoacoustic emission (DPOAE). In contrast, 1 mg/kg of cisplatin plus 200 mg/kg of furosemide resulted in a permanent 40-50 dB elevation of auditory brainstem response thresholds, almost complete elimination of DPOAE, and nearly total loss of outer hair cells. The widespread outer hair cell lesions that develop in mice treated with cisplatin plus furosemide could serve as extremely useful murine model for investigating techniques for regenerating outer hair cells, studying the mechanisms of cisplatin and furosemide ototoxicity and assessing the perceptual and electrophysiological consequences of outer hair cell loss on central auditory plasticity.
authors: Center for Hearing and Deafness, University at Buffalo, 137 Cary Hall, Buffalo, NY 14214, USA.
authors: Yongqi
authors: Y
authors: Li
authors: Dalian
authors: D
authors: Ding
authors: Haiyan
authors: H
authors: Jiang
authors: Yong
authors: Y
authors: Fu
authors: Richard
authors: R
authors: Salvi
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D001309:Auditory Threshold / Q000502:physiology; D016923:Cell Death / Q000187:drug effects; D002945:Cisplatin / Q000633:toxicity*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D055032:Electron Microscope Tomography; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects; D005665:Furosemide / Q000633:toxicity*; D006198:Hair Cells, Auditory / Q000187:drug effects* / Q000473:pathology / Q000648:ultrastructure; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D051379:Mice; D008808:Mice, Inbred CBA; D017084:Otoacoustic Emissions, Spontaneous / Q000187:drug effects; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000633:toxicity*; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D004338:Drug Combinations; D049994:Sodium Potassium Chloride Symporter Inhibitors; D005665:Furosemide; D002945:Cisplatin